The use of immunohistochemistry (IHC) in staging bone marrow in non-Hodgkin's lymphoma (NHL) is largely limited to ambiguous cases, particularly those with lymphoid aggregates. Its role in routine clinical practice remains unestablished. This study aime
peer reviewedDiffuse large B-cell lymphoma (DLBCL), the single largest category of lymphoma, is a cl...
BACKGROUND The International Prognostic Index (IPI) is used to determine prognosis in diffuse large ...
Aims: The clinical role of flow cytometry in staging bone marrow in diffuse large B-cell lymphoma (D...
Diffuse large B-cell lymphoma DLBCL is an aggressive non-Hodgkin's lymphoma NHL that requires treatm...
Aim: To evaluate the clinical significance of immunoperoxidase staining for CD10, bcl-6, mum-1 and b...
The results of immunohistochemical class prediction and prognostic stratification of diffuse large B...
Purpose: Until now molecular biologic techniques have not been easily used in daily clinical practic...
Item does not contain fulltextPURPOSE: The results of immunohistochemical class prediction and progn...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
BACKGROUND AND AIMS: The results of class prediction and the determination of prognostic markers in ...
The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers ...
The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers ...
BACKGROUND AND AIMS: The results of class prediction and the determination of prognostic markers in ...
Aims: It is known that advanced stage disease in diffuse large B-cell lymphoma (DLBCL) confers a poo...
PURPOSE: The results of immunohistochemical class prediction and prognostic stratification of diffus...
peer reviewedDiffuse large B-cell lymphoma (DLBCL), the single largest category of lymphoma, is a cl...
BACKGROUND The International Prognostic Index (IPI) is used to determine prognosis in diffuse large ...
Aims: The clinical role of flow cytometry in staging bone marrow in diffuse large B-cell lymphoma (D...
Diffuse large B-cell lymphoma DLBCL is an aggressive non-Hodgkin's lymphoma NHL that requires treatm...
Aim: To evaluate the clinical significance of immunoperoxidase staining for CD10, bcl-6, mum-1 and b...
The results of immunohistochemical class prediction and prognostic stratification of diffuse large B...
Purpose: Until now molecular biologic techniques have not been easily used in daily clinical practic...
Item does not contain fulltextPURPOSE: The results of immunohistochemical class prediction and progn...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
BACKGROUND AND AIMS: The results of class prediction and the determination of prognostic markers in ...
The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers ...
The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers ...
BACKGROUND AND AIMS: The results of class prediction and the determination of prognostic markers in ...
Aims: It is known that advanced stage disease in diffuse large B-cell lymphoma (DLBCL) confers a poo...
PURPOSE: The results of immunohistochemical class prediction and prognostic stratification of diffus...
peer reviewedDiffuse large B-cell lymphoma (DLBCL), the single largest category of lymphoma, is a cl...
BACKGROUND The International Prognostic Index (IPI) is used to determine prognosis in diffuse large ...
Aims: The clinical role of flow cytometry in staging bone marrow in diffuse large B-cell lymphoma (D...